Stimcell Energetics (STME) Change in Account Payables (2011 - 2026)
Stimcell Energetics' (STME) quarterly Change in Account Payables came in at -$8289.0 in Q1 2026, down 124.21% year-on-year from $34239.6 in Q1 2025, and down 129.13% quarter-over-quarter from $28460.0 in Q4 2025.
Stimcell Energetics (STME) Change in Account Payables (2011 - 2026) Analysis & Trends
Stimcell Energetics' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$8289.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 124.21% year-over-year to -$8289.0 in Q1 2026; TTM through Feb 2026 was $187621.0, a 145.03% increase from a year earlier, with the FY2025 full-year figure at $219596.0, up 190.68% from the prior year.
- Change in Account Payables retreated to -$8289.0 in Q1 2026 per STME's latest filing, from $28460.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $194932.0 in Q2 2025 and bottomed at -$75984.0 in Q1 2023.
- The 5-year median for Change in Account Payables is $11990.0 (2022), against an average of $17839.5.
- Across the five-year window, Change in Account Payables tumbled 533.82% in 2023 and surged 4140.06% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $30107.0 in 2022, then plunged by 36.26% to $19191.0 in 2023, then sank by 218.1% to -$22665.0 in 2024, then surged by 225.57% to $28460.0 in 2025, then plunged by 129.13% to -$8289.0 in 2026.
- Per Business Quant, the three latest STME Change in Account Payables figures stand at -$8289.0 (Q1 2026), $28460.0 (Q4 2025), and -$27482.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -8,289.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8,289.00 |
| Feb 28, 2026 | -8,289.00 |
| Nov 30, 2025 | 28,460.00 |
| Nov 30, 2025 | 28,460.00 |
| Aug 31, 2025 | -27,482.00 |
| Aug 31, 2025 | -27,482.00 |
| May 31, 2025 | 194,932.00 |
| May 31, 2025 | 194,932.00 |
| Feb 28, 2025 | -3,697.00 |
| Feb 28, 2025 | -3,697.00 |
| Nov 30, 2024 | -22,665.00 |
| Nov 30, 2024 | -22,665.00 |
| Aug 31, 2024 | 51,026.00 |
| Aug 31, 2024 | 51,026.00 |
| May 31, 2024 | 51,906.00 |
| May 31, 2024 | 51,906.00 |
| Feb 29, 2024 | 5,712.00 |
| Feb 29, 2024 | 5,712.00 |
| Nov 30, 2023 | 19,191.00 |
| Nov 30, 2023 | 19,191.00 |